Philip Morris International Inc. Presents at 2022 Barclays Global Consumer Staples Conference
06 September 2022 - 6:59PM
Business Wire
Regulatory News:
Philip Morris International Inc.’s (PMI) (NYSE: PM) Chief
Financial Officer, Emmanuel Babeau, will address investors today at
the Barclays Global Consumer Staples Conference in Boston.
The event will be webcast live in listen-only mode, beginning at
approximately 1:30 p.m. ET, at www.pmi.com/2022barclays and on the
PMI Investor Relations Mobile Application (available here).
Presentation slides will also be available on the same site and the
App.
An archived copy of the webcast will be available until 5:00
p.m. ET on Wednesday, October 5, 2022, also at
www.pmi.com/2022barclays.
Philip Morris International: Delivering a Smoke-Free
Future
Philip Morris International (PMI) is a leading international
tobacco company working to deliver a smoke-free future and evolving
its portfolio for the long term to include products outside of the
tobacco and nicotine sector. The company’s current product
portfolio primarily consists of cigarettes and smoke-free products,
including heat-not-burn, vapor and oral nicotine products, which
are sold in markets outside the U.S. Since 2008, PMI has invested
more than USD 9 billion to develop, scientifically substantiate and
commercialize innovative smoke-free products for adults who would
otherwise continue to smoke, with the goal of completely ending the
sale of cigarettes. This includes the building of world-class
scientific assessment capabilities, notably in the areas of
pre-clinical systems toxicology, clinical and behavioral research,
as well as post-market studies. The U.S. Food and Drug
Administration (FDA) has authorized the marketing of versions of
PMI’s IQOS Platform 1 devices and consumables as a Modified Risk
Tobacco Products (MRTPs), finding that an exposure modification
orders for these products are appropriate to promote the public
health. As of June 30, 2022, excluding Russia and Ukraine, PMI's
smoke-free products are available for sale in 70 markets, and PMI
estimates that approximately 13.2 million adults around the world
had already switched to IQOS and stopped smoking. With a strong
foundation and significant expertise in life sciences, in February
2021 PMI announced its ambition to expand into wellness and
healthcare areas and deliver innovative products and solutions that
aim to address unmet consumer and patient needs. For more
information, please visit www.pmi.com and www.pmiscience.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220906005779/en/
Philip Morris International
Investor Relations: New York: +1 (917) 663 2233 Lausanne: +41
(0)58 242 4666 Email: InvestorRelations@pmi.com
Media: David Fraser Lausanne: +41 (0)58 242 4500 Email:
David.Fraser@pmi.com
Philip Morris (NYSE:PM)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Philip Morris (NYSE:PM)
Historical Stock Chart
Von Mai 2023 bis Mai 2024